FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136187250> ?p ?o ?g. }

• W3136187250 endingPage "1410" @default.
• W3136187250 startingPage "1395" @default.
• W3136187250 abstract "Background and Aims Recent development of multiple treatments for human hepatocellular carcinoma (HCC) has allowed for the selection of combination therapy to enhance the effectiveness of monotherapy. Optimal selection of therapies is based on both HCC and its microenvironment. Therefore, it is critical to develop and validate preclinical animal models for testing clinical therapeutic solutions. Approach and Results We established cell line–based or patient‐derived xenograft–based humanized‐immune‐system mouse models with subcutaneous and orthotopic HCC. Mice were injected with human‐specific antibodies (Abs) to deplete human immune cells. We analyzed the transcription profiles of HCC cells and human immune cells by using real‐time PCR and RNA sequencing. The protein level of HCC tumor cells/tissues or human immune cells was determined by using flow cytometry, western blotting, and immunohistochemistry. The HCC tumor size was measured after single, dual‐combination, and triple‐combination treatment using N‐(1ʹ,2‐Dihydroxy‐1,2ʹ‐binaphthalen‐4ʹ‐yl)‐4‐methoxybenzenesulfonamide (C188‐9), bevacizumab, and pembrolizumab. In this study, human immune cells in the tumor microenvironment were strongly selected and modulated by HCC, which promoted the activation of the IL‐6/Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) signaling pathway in tumor cells and led to augmented HCC proliferation and angiogenesis by releasing angiogenic cytokines in humanized‐immune‐system mice with HCC. In particular, intratumor human cluster of differentiation–positive (hCD14 + ) cells could produce IL‐33 through damage‐associated molecular pattern/Toll‐like receptor 4/activator protein 1, which up‐regulated IL‐6 in other intratumor immune cells and activated the JAK2/STAT3 pathway in HCC. Specific knockdown of the CD14 gene in human monocytes could impair IL‐33 production induced by cell lysates. Subsequently, we evaluated the in vivo anti‐HCC effect of C188‐9, bevacizumab, and pembrolizumab. The results showed that the anti‐HCC effect of triple‐combination therapy was superior to that of single or dual treatments. Conclusions Humanized‐immune‐system HCC mouse models are suitable for identifying targets from cancer and immune components and for testing combinational therapies." @default.
• W3136187250 created "2021-03-29" @default.
• W3136187250 creator A5001422575 @default.
• W3136187250 creator A5007996484 @default.
• W3136187250 creator A5017353282 @default.
• W3136187250 creator A5017789638 @default.
• W3136187250 creator A5022940367 @default.
• W3136187250 creator A5027067638 @default.
• W3136187250 creator A5029489495 @default.
• W3136187250 creator A5030659181 @default.
• W3136187250 creator A5045076272 @default.
• W3136187250 creator A5048175048 @default.
• W3136187250 creator A5049981148 @default.
• W3136187250 creator A5056618658 @default.
• W3136187250 creator A5057368797 @default.
• W3136187250 creator A5063038462 @default.
• W3136187250 creator A5065729959 @default.
• W3136187250 creator A5075008412 @default.
• W3136187250 creator A5077541065 @default.
• W3136187250 date "2021-09-01" @default.
• W3136187250 modified "2023-10-16" @default.
• W3136187250 title "Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma–Immune Humanized Mouse Model" @default.
• W3136187250 cites W1174036299 @default.
• W3136187250 cites W1451771231 @default.
• W3136187250 cites W2000799034 @default.
• W3136187250 cites W2010417415 @default.
• W3136187250 cites W2016828736 @default.
• W3136187250 cites W2028525116 @default.
• W3136187250 cites W2037338605 @default.
• W3136187250 cites W2053951934 @default.
• W3136187250 cites W2057006907 @default.
• W3136187250 cites W2062030781 @default.
• W3136187250 cites W2073061707 @default.
• W3136187250 cites W2097213648 @default.
• W3136187250 cites W2103605927 @default.
• W3136187250 cites W2126481441 @default.
• W3136187250 cites W2127282925 @default.
• W3136187250 cites W2136977965 @default.
• W3136187250 cites W2138600064 @default.
• W3136187250 cites W2144332166 @default.
• W3136187250 cites W2144596831 @default.
• W3136187250 cites W2160809569 @default.
• W3136187250 cites W2165638318 @default.
• W3136187250 cites W2166965664 @default.
• W3136187250 cites W2204209053 @default.
• W3136187250 cites W2285354269 @default.
• W3136187250 cites W2289068089 @default.
• W3136187250 cites W2394486499 @default.
• W3136187250 cites W2409483347 @default.
• W3136187250 cites W2478438166 @default.
• W3136187250 cites W2515730340 @default.
• W3136187250 cites W2530255522 @default.
• W3136187250 cites W2532470837 @default.
• W3136187250 cites W2575311953 @default.
• W3136187250 cites W2592159070 @default.
• W3136187250 cites W2604023601 @default.
• W3136187250 cites W2618875352 @default.
• W3136187250 cites W2752189362 @default.
• W3136187250 cites W2754522390 @default.
• W3136187250 cites W2767554904 @default.
• W3136187250 cites W2787039411 @default.
• W3136187250 cites W2788763260 @default.
• W3136187250 cites W2794800012 @default.
• W3136187250 cites W2884815522 @default.
• W3136187250 cites W2885234188 @default.
• W3136187250 cites W2896456439 @default.
• W3136187250 cites W2908198004 @default.
• W3136187250 cites W2917766341 @default.
• W3136187250 cites W2930578043 @default.
• W3136187250 cites W2940287925 @default.
• W3136187250 cites W2952346511 @default.
• W3136187250 cites W2969246579 @default.
• W3136187250 cites W4214672256 @default.
• W3136187250 cites W4232620598 @default.
• W3136187250 cites W4249864493 @default.
• W3136187250 doi "https://doi.org/10.1002/hep.31812" @default.
• W3136187250 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33738839" @default.
• W3136187250 hasPublicationYear "2021" @default.
• W3136187250 type Work @default.
• W3136187250 sameAs 3136187250 @default.
• W3136187250 citedByCount "19" @default.
• W3136187250 countsByYear W31361872502021 @default.
• W3136187250 countsByYear W31361872502022 @default.
• W3136187250 countsByYear W31361872502023 @default.
• W3136187250 crossrefType "journal-article" @default.
• W3136187250 hasAuthorship W3136187250A5001422575 @default.
• W3136187250 hasAuthorship W3136187250A5007996484 @default.
• W3136187250 hasAuthorship W3136187250A5017353282 @default.
• W3136187250 hasAuthorship W3136187250A5017789638 @default.
• W3136187250 hasAuthorship W3136187250A5022940367 @default.
• W3136187250 hasAuthorship W3136187250A5027067638 @default.
• W3136187250 hasAuthorship W3136187250A5029489495 @default.
• W3136187250 hasAuthorship W3136187250A5030659181 @default.
• W3136187250 hasAuthorship W3136187250A5045076272 @default.
• W3136187250 hasAuthorship W3136187250A5048175048 @default.
• W3136187250 hasAuthorship W3136187250A5049981148 @default.
• W3136187250 hasAuthorship W3136187250A5056618658 @default.
• W3136187250 hasAuthorship W3136187250A5057368797 @default.

• next